Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals C Marques, C Mega, A Gonçalves, P Rodrigues-Santos, ... Mediators of inflammation 2014 (1), 538737, 2014 | 153 | 2014 |
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood–retinal barrier in a type 2 diabetes animal model A Gonçalves, E Leal, A Paiva, E Teixeira Lemos, F Teixeira, CF Ribeiro, ... Diabetes, Obesity and Metabolism 14 (5), 454-463, 2012 | 110 | 2012 |
Regulation of claudins in blood-tissue barriers under physiological and pathological states A Gonçalves, AF Ambrósio, R Fernandes Tissue barriers 1 (3), e24782, 2013 | 101 | 2013 |
Dipeptidyl peptidase-IV inhibition prevents blood–retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats A Gonçalves, C Marques, E Leal, CF Ribeiro, F Reis, AF Ambrósio, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 89 | 2014 |
Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood–retinal barrier breakdown and inflammation A Gonçalves, CM Lin, A Muthusamy, C Fontes-Ribeiro, AF Ambrósio, ... Investigative ophthalmology & visual science 57 (6), 2584-2592, 2016 | 63 | 2016 |
Organ-on-a-chip technologies for advanced blood–retinal barrier models H Ragelle, A Goncalves, S Kustermann, DA Antonetti, A Jayagopal Journal of ocular pharmacology and therapeutics 36 (1), 30-41, 2020 | 48 | 2020 |
The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation A Gonçalves, L Almeida, AP Silva, C Fontes-Ribeiro, AF Ambrósio, ... Biomedicine & Pharmacotherapy 102, 833-838, 2018 | 29 | 2018 |
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin A Goncalves, EJ Su, A Muthusamy, M Zeitelhofer, D Torrente, I Nilsson, ... Blood, The Journal of the American Society of Hematology 140 (4), 388-400, 2022 | 27 | 2022 |
Vascular expression of permeability-resistant occludin mutant preserves visual function in diabetes A Goncalves, A Dreffs, C Lin, S Sheskey, N Hudson, J Keil, M Campbell, ... Diabetes 70 (7), 1549-1560, 2021 | 22 | 2021 |
The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes C Marques, A Goncalves, PMR Pereira, D Almeida, B Martins, ... Life sciences 234, 116738, 2019 | 20 | 2019 |
Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS A Goncalves, DA Antonetti Fluids and barriers of the CNS 19 (1), 86, 2022 | 13 | 2022 |
Blood-Retinal Barrier R Fernandes, A Gonçalves, J Cunha-Vaz Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate …, 2012 | 1 | 2012 |
Regulation of intracellular heme modulates retinal angiogenesis A Goncalves, X Liu, N Santander, T Arnold, DA Antonetti Investigative Ophthalmology & Visual Science 63 (7), 3178–F0452-3178–F0452, 2022 | | 2022 |
Endothelial expression of permeability-resistant occludin mutant preserves visual function in diabetes C Lin, A Goncalves, JM Keil, S Sheskey, DA Antonetti Investigative Ophthalmology & Visual Science 60 (9), 2692-2692, 2019 | | 2019 |
Exendin-4, a glucagon-like peptide 1 receptor agonist, reduces retinal vascular permeability and prevents microglia activation in type 1 diabetes RC Fernandes, A Goncalves, L Costa, MI Barros, C Gomes, ... GLIA 67, E239-E239, 2019 | | 2019 |
Contribution of occludin S490 phosphorylation on blood retinal barrier integrity and visual function. A Goncalves, J Keil, S Sheskey, C Lin, D Antonetti Investigative Ophthalmology & Visual Science 59 (9), 3008-3008, 2018 | | 2018 |
Exendin-4, a glucagon-like peptide 1 analog, prevents the increase in blood-retinal barrier permeability and microglia activation in a type 1 diabetes animal model A Goncalves, MI Barros, J Martins, CA Gomes, C Fontes-Ribeiro, ... GLIA 65, E506-E507, 2017 | | 2017 |
Para Além da PMA... A Investigação Científica com Embriões: A Problemática Jurídica do Patenteamento das Invenções Biotecnológicas com Embriões Humanos AF Gonçalves PQDT-Global, 2017 | | 2017 |
Can DPP-IV Inhibitors or GLP-1 Analogs be Tomorrow’s Therapy for Diabetic Retinopathy? AFD Gonçalves PQDT-Global, 2016 | | 2016 |
AMELIORATION OF KIDNEY INFLAMMATION AND APOPTOTIC CELL DEATH IN AN ANIMAL MODEL OF TYPE 2 DIABETES C Marques, C Mega, A Goncalves, P Rodrigues-Santos, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 29, 174-174, 2014 | | 2014 |